Index -
P/E 25.32
EPS (ttm) 0.85
Insider Own 28.91%
Shs Outstand 6.42M
Perf Week 0.33%
Market Cap 137.24M
Forward P/E -
EPS next Y -
Insider Trans 0.00%
Shs Float 4.56M
Perf Month 1.52%
Income 5.50M
PEG -
EPS next Q -
Inst Own 21.30%
Short Float 0.81%
Perf Quarter 4.03%
Sales 48.08M
P/S 2.85
EPS this Y -
Inst Trans 2.94%
Short Ratio 2.03
Perf Half Y 29.76%
Book/sh 19.49
P/B 1.10
EPS next Y -
ROA 0.63%
Short Interest 0.04M
Perf Year 54.03%
Cash/sh -
P/C -
EPS next 5Y -
ROE 4.53%
52W Range 13.76 - 21.98
Perf YTD 34.06%
Dividend Est. -
P/FCF 28.18
EPS past 5Y 62.31%
ROI 3.11%
52W High -2.57%
Beta 0.53
Dividend TTM -
Quick Ratio -
Sales past 5Y 22.65%
Gross Margin -
52W Low 55.59%
ATR (14) 0.13
Dividend Ex-Date -
Current Ratio 0.33
EPS Y/Y TTM -17.67%
Oper. Margin 14.89%
RSI (14) 69.41
Volatility 0.36% 0.48%
Employees 91
Debt/Eq 0.41
Sales Y/Y TTM 19.65%
Profit Margin 11.45%
Recom -
Target Price -
Option/Short No / Yes
LT Debt/Eq 0.41
EPS Q/Q -35.16%
Payout 0.00%
Rel Volume 0.91
Prev Close 21.37
Sales Surprise -
EPS Surprise -
Sales Q/Q 12.02%
Earnings -
Avg Volume 18.22K
Price 21.41
SMA20 0.63%
SMA50 0.89%
SMA200 20.45%
Trades
Volume 16,589
Change 0.19%
Jul-26-24 08:52PM
04:30PM
May-31-24 07:39AM
May-30-24 04:15PM
Apr-26-24 09:52PM
04:30PM
Loading…
04:30PM
Feb-03-24 04:32AM
Feb-01-24 04:30PM
Oct-26-23 06:05PM
04:30PM
Jul-27-23 04:30PM
May-15-23 06:54AM
May-12-23 06:52AM
May-11-23 07:02AM
May-10-23 06:32AM
06:40AM
Loading…
May-09-23 06:40AM
May-08-23 06:41AM
May-05-23 06:58AM
May-04-23 06:29AM
May-03-23 06:46AM
May-02-23 06:46AM
May-01-23 06:45AM
Apr-28-23 07:04AM
Apr-27-23 04:30PM
06:47AM
Apr-26-23 06:26AM
Apr-20-23 07:03AM
Apr-19-23 06:53AM
Apr-17-23 06:54AM
Apr-14-23 06:37AM
06:37AM
Loading…
06:37AM
Apr-13-23 06:52AM
Apr-12-23 07:07AM
Apr-11-23 06:58AM
Apr-10-23 06:44AM
Apr-08-23 08:30AM
Apr-07-23 07:44AM
07:44AM
Apr-06-23 07:20AM
Apr-05-23 06:11AM
Apr-04-23 07:08AM
Apr-03-23 06:48AM
Mar-31-23 06:36AM
Mar-30-23 06:36AM
Mar-29-23 06:32AM
Mar-28-23 06:46AM
Mar-24-23 06:42AM
Mar-23-23 07:01AM
07:01AM
Feb-17-23 06:27AM
Feb-10-23 04:30PM
Oct-31-22 08:30AM
Oct-26-22 04:30PM
Aug-16-22 07:34AM
Jul-26-22 08:00PM
May-18-22 07:50AM
Apr-22-22 04:30PM
Apr-18-22 06:27AM
Mar-04-22 04:11AM
Feb-22-22 05:05PM
Feb-07-22 05:38PM
Jan-27-22 04:30PM
Jan-18-22 04:00AM
Dec-04-21 06:09AM
Oct-31-21 08:01AM
Oct-27-21 09:00PM
Jul-27-21 01:35AM
Jan-27-21 11:22PM
Jan-26-21 11:26PM
Affinity Bancshares, Inc. is a holding company, which engages in the savings and loan business. It is also involved in the investing business. The company was founded in September 2020 and is headquartered in Covington, GA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Roberts Howard G Director Nov 20 '23 Buy 14.48 400 5,792 2,906 Nov 22 10:10 AM
Index S&P 500
P/E 28.43
EPS (ttm) 4.83
Insider Own 0.40%
Shs Outstand 292.12M
Perf Week -3.74%
Market Cap 39.42B
Forward P/E 24.26
EPS next Y 5.66
Insider Trans -6.84%
Shs Float 286.18M
Perf Month 2.42%
Income 1.41B
PEG 5.69
EPS next Q 1.41
Inst Own 93.46%
Short Float 1.00%
Perf Quarter 3.30%
Sales 6.50B
P/S 6.07
EPS this Y -3.74%
Inst Trans -3.35%
Short Ratio 1.47
Perf Half Y -8.11%
Book/sh 20.53
P/B 6.68
EPS next Y 8.01%
ROA 13.04%
Short Interest 2.86M
Perf Year 16.33%
Cash/sh 6.19
P/C 22.16
EPS next 5Y 5.00%
ROE 24.66%
52W Range 96.80 - 155.35
Perf YTD -1.32%
Dividend Est. 0.94 (0.68%)
P/FCF 27.82
EPS past 5Y 33.93%
ROI 17.57%
52W High -11.68%
Beta 1.05
Dividend TTM 0.93 (0.68%)
Quick Ratio 1.37
Sales past 5Y 7.00%
Gross Margin 54.84%
52W Low 41.74%
ATR (14) 3.05
Dividend Ex-Date Jul 02, 2024
Current Ratio 1.78
EPS Y/Y TTM 26.31%
Oper. Margin 24.49%
RSI (14) 45.76
Volatility 2.36% 1.93%
Employees 18100
Debt/Eq 0.50
Sales Y/Y TTM -7.11%
Profit Margin 21.75%
Recom 2.41
Target Price 147.17
Option/Short Yes / Yes
LT Debt/Eq 0.36
EPS Q/Q 157.53%
Payout 21.48%
Rel Volume 0.67
Prev Close 138.36
Sales Surprise 1.32%
EPS Surprise 4.85%
Sales Q/Q -5.62%
Earnings Aug 21 AMC
Avg Volume 1.95M
Price 137.20
SMA20 -1.56%
SMA50 1.35%
SMA200 0.38%
Trades
Volume 1,297,513
Change -0.84%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-28-24 Initiated
Wells Fargo
Overweight
$157
Jul-10-24 Upgrade
Citigroup
Neutral → Buy
$135 → $150
Jun-27-24 Downgrade
Wolfe Research
Outperform → Peer Perform
Jun-03-24 Resumed
Jefferies
Hold
$135
Apr-05-24 Upgrade
Stifel
Hold → Buy
$145 → $163
Dec-13-23 Initiated
Wolfe Research
Outperform
$140
Dec-12-23 Downgrade
BofA Securities
Buy → Neutral
$130 → $133
Nov-17-23 Downgrade
UBS
Buy → Neutral
$163 → $125
Sep-28-23 Initiated
Bernstein
Mkt Perform
$123
Jul-31-23 Downgrade
Evercore ISI
Outperform → In-line
$126 → $124
May-24-23 Reiterated
Wells Fargo
Overweight
$170 → $160
May-24-23 Reiterated
TD Cowen
Outperform
$168 → $145
May-24-23 Reiterated
SVB Securities
Outperform
$170 → $145
May-24-23 Reiterated
Stifel
Hold
$153 → $135
May-24-23 Reiterated
Robert W. Baird
Outperform
$174 → $144
May-24-23 Reiterated
Evercore ISI
Outperform
$150 → $126
May-24-23 Reiterated
Credit Suisse
Outperform
$170 → $160
May-24-23 Reiterated
Citigroup
Neutral
$150 → $130
May-24-23 Reiterated
BofA Securities
Buy
$164 → $144
May-24-23 Reiterated
Barclays
Equal Weight
$140 → $135
Show Previous Ratings
Sep-02-24 07:33AM
Aug-31-24 01:04AM
Aug-28-24 09:34AM
Aug-26-24 09:15AM
Aug-23-24 03:00PM
12:50PM
Loading…
Aug-22-24 12:50PM
09:51AM
(Thomson Reuters StreetEvents)
Aug-21-24 09:28PM
08:53PM
06:00PM
05:15PM
04:13PM
(Associated Press Finance)
04:05PM
Aug-20-24 10:29AM
09:01AM
10:18AM
Loading…
Aug-19-24 10:18AM
Aug-18-24 02:00PM
Aug-16-24 09:15AM
Aug-15-24 08:00AM
Aug-14-24 10:00AM
Aug-12-24 12:58PM
Aug-02-24 08:00AM
Jul-31-24 07:25PM
Jul-30-24 01:01PM
Jul-29-24 09:55AM
Jul-26-24 03:35PM
Jul-25-24 04:09PM
Jul-24-24 07:24AM
Jul-23-24 06:33AM
(Pharmaceutical Technology)
Jul-22-24 11:19AM
10:47AM
Loading…
10:47AM
09:01AM
Jul-21-24 09:12PM
Jul-19-24 08:46AM
Jul-16-24 04:01PM
Jul-13-24 12:05PM
Jul-01-24 01:04PM
09:01AM
Jun-28-24 11:30AM
Jun-27-24 12:06PM
09:48AM
Jun-26-24 10:07AM
Jun-21-24 03:10AM
Jun-14-24 06:54AM
Jun-06-24 12:01PM
Jun-03-24 11:27AM
11:00AM
May-31-24 07:34PM
May-30-24 04:24PM
02:36PM
12:15PM
(Associated Press Finance)
11:58AM
11:34AM
07:47AM
07:39AM
07:34AM
06:38AM
(Thomson Reuters StreetEvents)
May-29-24 08:53PM
06:00PM
05:15PM
04:14PM
(Associated Press Finance)
04:05PM
May-28-24 11:44AM
May-26-24 07:00AM
May-23-24 04:05PM
09:15AM
08:04AM
May-22-24 04:05PM
10:00AM
08:00AM
May-17-24 02:30PM
May-16-24 10:59AM
08:00AM
May-13-24 09:30AM
May-02-24 04:53PM
12:10PM
11:45AM
09:30AM
May-01-24 10:31AM
08:45AM
08:00AM
Apr-29-24 08:45AM
Apr-18-24 04:30PM
Apr-16-24 08:00AM
Apr-15-24 08:00AM
Apr-09-24 11:37PM
12:02PM
10:41AM
Apr-05-24 09:55AM
Apr-04-24 08:00AM
Apr-03-24 08:00AM
Apr-02-24 11:15AM
08:00AM
Apr-01-24 08:00AM
Mar-29-24 09:30AM
Mar-28-24 11:30AM
Mar-27-24 05:01PM
Mar-26-24 02:00AM
Mar-14-24 08:00AM
Mar-12-24 05:00PM
Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment consists of activity providing active pharmaceutical ingredients for oligo-based therapeutics, as well as solutions that include reagents, instruments, software and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
MCDONNELL PADRAIG President and CEO Aug 22 '24 Sale 145.00 1,958 283,910 24,118 Aug 23 11:43 AM MCDONNELL PADRAIG Officer Aug 22 '24 Proposed Sale 145.00 1,958 283,910 Aug 22 12:39 PM MCDONNELL PADRAIG President and CEO Jul 26 '24 Sale 140.00 1,958 274,120 26,076 Jul 30 10:42 AM MCDONNELL PADRAIG Officer Jul 26 '24 Proposed Sale 140.00 1,958 274,120 Jul 26 10:56 AM MCDONNELL PADRAIG President and CEO Jun 18 '24 Sale 135.00 1,958 264,330 28,034 Jun 20 06:54 PM Grau Dominique Senior Vice President Jun 10 '24 Sale 133.28 15,000 1,999,262 49,486 Jun 12 10:40 AM MCDONNELL PADRAIG President and CEO Jun 03 '24 Sale 130.00 1,958 254,540 25,185 Jun 05 10:08 AM Binns Philip Senior Vice President Mar 25 '24 Sale 147.54 2,827 417,096 9,997 Mar 27 01:29 PM McMullen Michael R. CEO and President Mar 08 '24 Sale 150.00 52,297 7,844,550 253,909 Mar 12 02:37 PM Gonsalves Rodney V.P., Corporate Controller Mar 07 '24 Sale 149.00 4,828 719,348 21,329 Mar 08 12:05 PM FIELDS HEIDI Director Mar 05 '24 Sale 144.34 1,658 239,316 54,976 Mar 07 10:38 AM Binns Philip Senior Vice President Dec 27 '23 Sale 139.78 2,880 402,566 12,824 Dec 28 01:46 PM Gonsalves Rodney V.P., Corporate Controller Dec 18 '23 Sale 137.69 1,500 206,538 26,133 Dec 19 02:34 PM Ancher-Jensen Henrik Sr Vice President Dec 15 '23 Option Exercise 111.36 11,703 1,303,235 108,835 Dec 19 02:33 PM Ancher-Jensen Henrik Sr Vice President Dec 15 '23 Sale 138.36 26,331 3,643,157 82,504 Dec 19 02:33 PM McMullen Michael R. CEO and President Dec 13 '23 Option Exercise 42.12 2,751 115,872 308,957 Dec 15 05:08 PM McMullen Michael R. CEO and President Dec 13 '23 Sale 130.00 2,751 357,630 306,206 Dec 15 05:08 PM McMullen Michael R. CEO and President Dec 07 '23 Option Exercise 42.12 62,467 2,631,110 368,673 Dec 08 02:59 PM McMullen Michael R. CEO and President Dec 07 '23 Sale 130.00 62,467 8,120,710 306,206 Dec 08 02:59 PM Gonsalves Rodney V.P., Corporate Controller Sep 28 '23 Buy 111.09 3 288 24,222 Sep 29 04:03 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite